Condition: As New. Unread book in perfect condition.
Condition: New.
Seller: Rarewaves USA, OSWEGO, IL, U.S.A.
Hardback. Condition: New. The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety.
Language: English
Published by Boston, MA, Springer US., 2016
ISBN 10: 1489977929 ISBN 13: 9781489977922
Seller: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germany
XIII,105 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 1st edition. 143 pages. 9.25x6.75x0.50 inches. In Stock.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Language: English
Published by Walter de Gruyter, Incorporated, 2012
ISBN 10: 3110266202 ISBN 13: 9783110266207
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. pp. xii + 143 28 Figures.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 33.17
Quantity: Over 20 available
Add to basketCondition: New. In.
Condition: New.
Condition: New.
Seller: BargainBookStores, Grand Rapids, MI, U.S.A.
Paperback or Softback. Condition: New. Clinical Core Laboratory Testing. Book.
Language: English
Published by Walter de Gruyter, Incorporated, 2012
ISBN 10: 3110266202 ISBN 13: 9783110266207
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New.
Condition: As New. Unread book in perfect condition.
Condition: As New. Unread book in perfect condition.
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
First Edition
Condition: New. 2012. 1st Edition. hardcover. . . . . .
£ 48.98
Quantity: Over 20 available
Add to basketCondition: New. In.
£ 50.43
Quantity: Over 20 available
Add to basketCondition: New. In.
Condition: New.
Condition: New. Softcover reprint of the original 1st ed. 2017 edition NO-PA16APR2015-KAP.
Condition: New.
Condition: New.
Seller: Rarewaves USA United, OSWEGO, IL, U.S.A.
Hardback. Condition: New. The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety.
Condition: New. 2012. 1st Edition. hardcover. . . . . . Books ship from the US and Ireland.
Condition: As New. Unread book in perfect condition.
Condition: As New. Unread book in perfect condition.
Hardcover. Condition: Brand New. 1st edition. 105 pages. 9.25x6.25x0.50 inches. In Stock.
Language: English
Published by De Gruyter, De Gruyter, 2012
ISBN 10: 3110266202 ISBN 13: 9783110266207
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety.
Taschenbuch. Condition: Neu. Endogenous Interferences in Clinical Laboratory Tests | Icteric, Lipemic and Turbid Samples | Christopher R. Mccudden (u. a.) | Taschenbuch | Patient Safety | XII | Englisch | 2012 | De Gruyter | EAN 9783110266207 | Verantwortliche Person für die EU: Walter de Gruyter GmbH, De Gruyter GmbH, Genthiner Str. 13, 10785 Berlin, productsafety[at]degruyterbrill[dot]com | Anbieter: preigu.
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The clinical laboratory is often known as a 'black box' to nurses, physicians, and surgeons, but this concise book removes the veil by covering all the pertinent aspects of the clinical laboratory. This book bridges between medicine and chemistry by offering an overview to a clinical laboratory's structure and function, the importance of laboratory utilization and test ordering, as well as pre-analytical, analytical, and post-analytical issues of importance to recognize in any clinical laboratory. An interactive FAQ and a detailed index are also available.